(Q34749766)

4 August 2017

1 reference

title

Synergism between HIV and other viruses in the mouth (English)

1 reference

4 August 2017

4

Crispian Scully

1 reference

4 August 2017

author name string

François-Xavier Mbopi-Kéou

1

1 reference

4 August 2017

Laurent Bélec

2

1 reference

4 August 2017

Chong G Teo

3

1 reference

4 August 2017

Stephen R Porter

5

1 reference

4 August 2017

publication date

1 July 2002

1 reference

Lancet Infectious Diseases

4 August 2017

published in

1 reference

4 August 2017

volume

2

1 reference

4 August 2017

issue

7

1 reference

4 August 2017

page(s)

416-424

1 reference

Oral transmission of HIV.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Oral sex and the transmission of viral STIs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Transmission of human immunodeficiency virus type 1 through breast-feeding: how can it be prevented?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Intrapartum mucosal exposure to human immunodeficiency virus type 1 (HIV-1) of infants born to HIV-1-infected mothers correlates with maternal plasma virus burden.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Infection of Macaca nemestrina neonates with HIV-1 via different routes of inoculation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Oral transmission of primate lentiviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Feline immunodeficiency virus clade C mucosal transmission and disease courses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Mucosal dendritic cells and immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Hepatitis C virus infection: Review and implications for the dentist

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Detection of HIV in oral mucosal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

High numbers of T cells in gingiva from patients with human immunodeficiency virus (HIV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Outpatient biopsies of the palatine tonsil: access to lymphoid tissue for assessment of human immunodeficiency virus RNA titers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Crack cocaine smoking and oral sores in three inner-city neighborhoods

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Components of saliva inactivate human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

The anti-HIV-1 activity associated with saliva

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Endogenous salivary inhibitors of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Prevalence of the diffuse infiltrative lymphocytosis syndrome among human immunodeficiency virus type 1-positive outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Prevalence of Sjögren's-like syndrome in a cohort of HIV-1-positive patients: descriptive pathology and immunopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Genital herpes simplex virus type 2 shedding is increased in HIV-infected women in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Activation of human immunodeficiency virus by herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

The impact of active herpes simplex virus infection on human immunodeficiency virus load

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Cell-dependent mechanisms restrict the HIV type 1 coreceptor activity of US28, a chemokine receptor homolog encoded by human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Enhanced HIV-1 replication in V beta 12 T cells due to human cytomegalovirus in monocytes: evidence for a putative herpesvirus superantigen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Infection of primary CD4+ and CD8+ T lymphocytes by Epstein-Barr virus enhances human immunodeficiency virus expression

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

An Epstein-Barr virus-associated superantigen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Risk factors associated with Epstein-Barr virus replication in oral epithelial cells of HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Tissue distribution of Epstein-Barr virus genotypes in hosts coinfected by HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Human herpesvirus 6 in salivary glands

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Interactions between beta-herpesviruses and human immunodeficiency virus in vivo: evidence for increased human immunodeficiency viral load in the presence of human herpesvirus 6.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Human herpesvirus 8 and oral health care: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Mucosal shedding of human herpesvirus 8 in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Presence of human herpesvirus 8 variants in the oral tissues of human immunodeficiency virus-infected persons.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Quantitation of 8 human herpesviruses in peripheral blood of human immunodeficiency virus-infected patients and healthy blood donors by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) ORF50 interacts synergistically with the tat gene product in transactivating the human immunodeficiency virus type 1 LTR.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Reciprocal regulatory interaction between human herpesvirus 8 and human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Effect of human immunodeficiency virus-1 protease inhibitors on the clearance of human herpesvirus 8 from blood of human immunodeficiency virus-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Novel HPV types present in oral papillomatous lesions from patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Human immunodeficiency virus infection is a major risk factor for detection of human papillomavirus DNA in esophageal brushings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

CD68+ cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic-sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Herpesviruses in HIV-periodontitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Herpesviruses 6, 7 and 8 in HIV- and non-HIV-associated periodontitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Relationship of cytomegalovirus to salivary gland dysfunction in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Cause of oral ulcers in HIV-infected patients: a study of 19 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Herpesviridae-associated persistent mucocutaneous ulcers in acquired immunodeficiency syndrome. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Necrotizing ulcerative stomatitis in human immunodeficiency virus-seropositive individuals: a review of the histopathologic, immunohistochemical, and virologic characteristics of 18 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Host factors and the pathogenesis of HIV-induced disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Cytokine modulation of HIV expression

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Cytokine profiles in parotid saliva from HIV-1-infected individuals: changes associated with opportunistic infections in the oral cavity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Enhanced interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in gingival crevicular fluid from periodontal pockets of patients infected with human immunodeficiency virus 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Molecular pathways in virus-induced cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Prevalence and prognostic significance of infection with TT virus in patients infected with human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Inverse relationship between the titre of TT virus DNA and the CD4 cell count in patients infected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Detection of hepatitis C virus RNA from gingival crevicular fluid and its relation to virus presence in saliva

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Effect of coinfection with GB virus C on survival among patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Infection with GB virus C and reduced mortality among HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

Investigation of saliva, faeces, urine or semen samples for the presence of GBV-C RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900317-1

7 January 2021

10.1016/S1473-3099(02)00317-1

Identifiers

DOI

1 reference

4 August 2017

1 reference